Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

Influence of Genetic Variants in TPMT and COMT Associated with Cisplatin Induced Hearing Loss in Patients with Cancer: Two New Cohorts and a Meta-Analysis Reveal Significant Heterogeneity between Cohorts.

Hagleitner MM, Coenen MJ, Patino-Garcia A, de Bont ES, Gonzalez-Neira A, Vos HI, van Leeuwen FN, Gelderblom H, Hoogerbrugge PM, Guchelaar HJ, Te Loo MW.

PLoS One. 2014 Dec 31;9(12):e115869. doi: 10.1371/journal.pone.0115869. eCollection 2014.

PMID:
25551397
[PubMed - in process]
Free PMC Article
2.

A germ line mutation in cathepsin B points toward a role in asparaginase pharmacokinetics.

van der Meer LT, Waanders E, Levers M, Venselaar H, Roeleveld D, Boos J, Lanvers C, Brüggemann RJ, Kuiper RP, Hoogerbrugge PM, van Leeuwen FN, te Loo DM.

Blood. 2014 Nov 6;124(19):3027-9. doi: 10.1182/blood-2014-06-582627. No abstract available.

PMID:
25377564
[PubMed - indexed for MEDLINE]
3.

Outcome of central nervous system relapses in childhood acute lymphoblastic leukaemia--prospective open cohort analyses of the ALLR3 trial.

Masurekar AN, Parker CA, Shanyinde M, Moorman AV, Hancock JP, Sutton R, Ancliff PJ, Morgan M, Goulden NJ, Fraser C, Hoogerbrugge PM, Revesz T, Darbyshire PJ, Krishnan S, Love SB, Saha V.

PLoS One. 2014 Oct 3;9(10):e108107. doi: 10.1371/journal.pone.0108107. eCollection 2014.

PMID:
25279465
[PubMed - in process]
Free PMC Article
4.

HDAC inhibitors and immunotherapy; a double edged sword?

Kroesen M, Gielen P, Brok IC, Armandari I, Hoogerbrugge PM, Adema GJ.

Oncotarget. 2014 Aug 30;5(16):6558-72.

PMID:
25115382
[PubMed - in process]
Free PMC Article
5.

The optimal use of PEG-asparaginase in relapsed ALL--lessons from the ALLR3 Clinical Trial.

Masurekar A, Fong C, Hussein A, Revesz T, Hoogerbrugge PM, Love S, Ciria C, Parker C, Krishnan S, Saha V.

Blood Cancer J. 2014 Apr 25;4:e203. doi: 10.1038/bcj.2014.26. No abstract available.

PMID:
24769644
[PubMed - in process]
Free PMC Article
6.

Self-perception and quality of life in adolescents during treatment for a primary malignant bone tumour.

van Riel CA, Meijer-van den Bergh EE, Kemps HL, Feuth T, Schreuder HW, Hoogerbrugge PM, De Groot IJ, Mavinkurve-Groothuis AM.

Eur J Oncol Nurs. 2014 Jun;18(3):267-72. doi: 10.1016/j.ejon.2014.01.005. Epub 2014 Mar 18.

PMID:
24656419
[PubMed - indexed for MEDLINE]
7.

Patient reported outcomes in pediatric oncology practice: suggestions for future usage by parents and pediatric oncologists.

Schepers SA, Engelen VE, Haverman L, Caron HN, Hoogerbrugge PM, Kaspers GJ, Egeler RM, Grootenhuis MA.

Pediatr Blood Cancer. 2014 Sep;61(9):1707-10. doi: 10.1002/pbc.25034. Epub 2014 Mar 20.

PMID:
24648289
[PubMed - indexed for MEDLINE]
8.

A transplantable TH-MYCN transgenic tumor model in C57Bl/6 mice for preclinical immunological studies in neuroblastoma.

Kroesen M, Nierkens S, Ansems M, Wassink M, Orentas RJ, Boon L, den Brok MH, Hoogerbrugge PM, Adema GJ.

Int J Cancer. 2014 Mar 15;134(6):1335-45. doi: 10.1002/ijc.28463. Epub 2013 Sep 14.

PMID:
24038106
[PubMed - indexed for MEDLINE]
9.

Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL.

van der Veer A, Waanders E, Pieters R, Willemse ME, Van Reijmersdal SV, Russell LJ, Harrison CJ, Evans WE, van der Velden VH, Hoogerbrugge PM, Van Leeuwen F, Escherich G, Horstmann MA, Mohammadi Khankahdani L, Rizopoulos D, De Groot-Kruseman HA, Sonneveld E, Kuiper RP, Den Boer ML.

Blood. 2013 Oct 10;122(15):2622-9. doi: 10.1182/blood-2012-10-462358. Epub 2013 Aug 23.

PMID:
23974192
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Adequate endocrine and cardiovascular response to social stress in survivors of childhood acute lymphoblastic leukemia.

Gordijn MS, Gemke RJ, Bierings MB, Hoogerbrugge PM, Tersteeg-Kamperman MD, Heijnen CJ, Rotteveel J, Kaspers GJ.

Psychoneuroendocrinology. 2013 Dec;38(12):3145-9. doi: 10.1016/j.psyneuen.2013.07.013. Epub 2013 Aug 5.

PMID:
23972944
[PubMed - indexed for MEDLINE]
11.

The role of the MTHFR 677C>T polymorphism in methotrexate-induced liver toxicity: a meta-analysis in patients with cancer.

Hagleitner MM, Coenen MJ, Aplenc R, Patiño-Garcia A, Chiusolo P, Gemmati D, De Mattei M, Ongaro A, Krajinovic M, Hoogerbrugge PM, Vermeulen SH, te Loo DM.

Pharmacogenomics J. 2014 Apr;14(2):115-9. doi: 10.1038/tpj.2013.19. Epub 2013 May 7.

PMID:
23648444
[PubMed - indexed for MEDLINE]
12.

High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation.

Marshall GM, Dalla Pozza L, Sutton R, Ng A, de Groot-Kruseman HA, van der Velden VH, Venn NC, van den Berg H, de Bont ES, Maarten Egeler R, Hoogerbrugge PM, Kaspers GJ, Bierings MB, van der Schoot E, van Dongen J, Law T, Cross S, Mueller H, de Haas V, Haber M, Révész T, Alvaro F, Suppiah R, Norris MD, Pieters R.

Leukemia. 2013 Jul;27(7):1497-503. doi: 10.1038/leu.2013.44. Epub 2013 Feb 14.

PMID:
23407458
[PubMed - indexed for MEDLINE]
13.

Absolute lymphocyte count predicts the response to new influenza virus H1N1 vaccination in pediatric cancer patients.

Mavinkurve-Groothuis AM, van der Flier M, Stelma F, van Leer-Buter C, Preijers FW, Hoogerbrugge PM.

Clin Vaccine Immunol. 2013 Jan;20(1):118-21. doi: 10.1128/CVI.00585-12. Epub 2012 Nov 21.

PMID:
23175288
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Myocardial 2D strain echocardiography and cardiac biomarkers in children during and shortly after anthracycline therapy for acute lymphoblastic leukaemia (ALL): a prospective study.

Mavinkurve-Groothuis AM, Marcus KA, Pourier M, Loonen J, Feuth T, Hoogerbrugge PM, de Korte CL, Kapusta L.

Eur Heart J Cardiovasc Imaging. 2013 Jun;14(6):562-9. doi: 10.1093/ehjci/jes217. Epub 2012 Oct 29.

PMID:
23109647
[PubMed - indexed for MEDLINE]
15.

Sleep, fatigue, depression, and quality of life in survivors of childhood acute lymphoblastic leukemia.

Gordijn MS, van Litsenburg RR, Gemke RJ, Huisman J, Bierings MB, Hoogerbrugge PM, Kaspers GJ.

Pediatr Blood Cancer. 2013 Mar;60(3):479-85. doi: 10.1002/pbc.24261. Epub 2012 Aug 8.

PMID:
22887764
[PubMed - indexed for MEDLINE]
16.

Hypothalamic-pituitary-adrenal axis function in survivors of childhood acute lymphoblastic leukemia and healthy controls.

Gordijn MS, van Litsenburg RR, Gemke RJ, Bierings MB, Hoogerbrugge PM, van de Ven PM, Heijnen CJ, Kaspers GJ.

Psychoneuroendocrinology. 2012 Sep;37(9):1448-56. doi: 10.1016/j.psyneuen.2012.01.014. Epub 2012 Mar 2.

PMID:
22385687
[PubMed - indexed for MEDLINE]
17.

The origin and nature of tightly clustered BTG1 deletions in precursor B-cell acute lymphoblastic leukemia support a model of multiclonal evolution.

Waanders E, Scheijen B, van der Meer LT, van Reijmersdal SV, van Emst L, Kroeze Y, Sonneveld E, Hoogerbrugge PM, van Kessel AG, van Leeuwen FN, Kuiper RP.

PLoS Genet. 2012;8(2):e1002533. doi: 10.1371/journal.pgen.1002533. Epub 2012 Feb 16.

PMID:
22359517
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Importance of neutropenia for development of invasive infections at various phases of treatment for hemato-oncological diseases in children.

Zwitserloot AM, Mavinkurve-Groothuis AM, Galama JM, Verweij PE, Hoogerbrugge PM, Warris A.

Scand J Infect Dis. 2012 May;44(5):355-62. doi: 10.3109/00365548.2011.641505. Epub 2012 Jan 4.

PMID:
22216875
[PubMed - indexed for MEDLINE]
19.

Favorable outcome of chronic disseminated candidiasis in four pediatric patients with hematological malignancies.

Donker AE, Mavinkurve-Groothuis AM, van Die LE, Verweij PE, Hoogerbrugge PM, Warris A.

Med Mycol. 2012 Apr;50(3):315-9. doi: 10.3109/13693786.2011.588256. Epub 2011 Nov 22.

PMID:
22103343
[PubMed - indexed for MEDLINE]
20.

Age as prognostic factor in patients with osteosarcoma.

Hagleitner MM, Hoogerbrugge PM, van der Graaf WT, Flucke U, Schreuder HW, te Loo DM.

Bone. 2011 Dec;49(6):1173-7. doi: 10.1016/j.bone.2011.08.014. Epub 2011 Aug 26.

PMID:
21893224
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk